IRCT20191211045693N1招募中3 期
Effects of compound Ma-ol-asal syrup on cancer-related fatigue in gastrointestinal (GI) cancer patients who are undergoing chemotherapy
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 78 years(—)
- 性别
- All
入选标准
- •1.Age between 18- 70 years old
- •2. GI cancer (pathologically diagnosed)
- •3.Undergoing chemotherapy
- •4. Hemoglobin level at least 10g/dl
- •5. Hematocrit level at least 30% .
- •6. No clinical symptom of hypothyroidism
- •7. Visual Analogue Fatigue Scale (VAS)>=4
排除标准
- •1. Heart disease with unstable conditions
- •2. Liver disease with unstable conditions
- •3. Disabling pulmonary disease
- •4. Positive history of hypersensitivity to honey and its compounds
- •5. Positive history of hypersensitivity to each component of the compound Ma-ol-asal syrup.
- •6. Uncontrolled pain.
- •7. An individual who uses treatment due to known psychiatric disease
- •8.Pregnancy.
- •9. Simultaneous use of drugs that affect fatigue.
- •10. kidney disease with unstable conditions
- •11. Severe infection
- •12. Serious accompanying disease.
研究者
相似试验
已完成
3 期
Effects of syrup of Jollab on fatigue in patients with breast cancerIRCT20150825023753N8Shahid Beheshti University of Medical Sciences60
已完成
不适用
The effect of compound Ma-ol-asal on treatment of the pediatric asthmaAsthma.AsthmaIRCT2015083123834N1Shahid Beheshti University of Medical Sciences80
已完成
3 期
The effect of compound Ma-ol-asal on treatment of the adult asthmaAsthma.AsthmaIRCT20181115041664N1Shahid Beheshti University of Medical Sciences80
已完成
2 期
The effect of compound Ma-ol-asal of chronic obstructive pulmonary disease (COPD) patientsChronic Obstructive Pulmonary Disease (COPD).Chronic obstructive pulmonary disease, unspecifiedJ44.9IRCT20190217042737N2Bagheiat-allah University of Medical Sciences76
招募中
2 期
The effect of compound ma_ol_asal” syrup on oligomenorrhea in patients with polycystic ovary syndromeIRCT20200112046087N5Traditional Medicine and Materia Medica Research Center20
